Implications of COVID-19 for patients with pre-existing digestive diseases
- PMID: 32171057
- PMCID: PMC7103943
- DOI: 10.1016/S2468-1253(20)30076-5
Implications of COVID-19 for patients with pre-existing digestive diseases
Erratum in
-
Correction to Lancet Gastroenterol Hepatol 2020; 5: 425-27.Lancet Gastroenterol Hepatol. 2020 Jul;5(7):e6. doi: 10.1016/S2468-1253(20)30150-3. Epub 2020 May 10. Lancet Gastroenterol Hepatol. 2020. PMID: 32401708 Free PMC article. No abstract available.
Comment in
-
Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak.Lancet Gastroenterol Hepatol. 2020 Jun;5(6):525. doi: 10.1016/S2468-1253(20)30085-6. Epub 2020 Mar 25. Lancet Gastroenterol Hepatol. 2020. PMID: 32220656 Free PMC article. No abstract available.
-
Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China.Lancet Gastroenterol Hepatol. 2020 Jun;5(6):525-527. doi: 10.1016/S2468-1253(20)30121-7. Epub 2020 Apr 17. Lancet Gastroenterol Hepatol. 2020. PMID: 32311321 Free PMC article. No abstract available.
-
Implications of COVID-19 for patients with pre-existing digestive diseases: an update.Lancet Gastroenterol Hepatol. 2021 Apr;6(4):258-260. doi: 10.1016/S2468-1253(21)00025-X. Epub 2021 Feb 2. Lancet Gastroenterol Hepatol. 2021. PMID: 33539813 Free PMC article. No abstract available.
References
-
- Liu Q, Wang R, Qu G, et al. Macroscopic autopsy findings in a patient with COVID-19. J Forensic Med. 2020;36:1–3. (in Chinese).
MeSH terms
LinkOut - more resources
Full Text Sources
Medical